Breaking News

Soligenix Inc (SNGX)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

1.2700 -0.0100 -0.78%

29/07 - Closed. Currency in USD

After Hours

1.2586

-0.0114

-0.8976%

23:31:40 - Real-time Data

Type: Equity

Market: United States

Volume: 390,613
Bid/Ask: 0.0000 / 0.0000
Day's Range: 1.1800 - 1.3200

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Soligenix Inc Company Profile

Get an in-depth profile of Soligenix Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ORD

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in Phase 3 clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX945, an IDR technology that is in Phase 2a study to treat aphthous ulcers in Behçet’s disease; and SGX302, an IDR technology, which is in Phase 2a study for the treatment of mild-to-moderate psoriasis. Its Public Health Solutions segment engages in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a, 1b, and 1c clinical trials; SGX943, a therapeutic candidate in preclinical studies for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; CiVax, a vaccine candidate for the prevention of COVID-19; and vaccine programs that target filoviruses, such as Marburg and Ebola. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in September 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.

Contact Information

Address 29 Emmons Drive Suite B-10
Princeton, 08540
United States

Phone 609 538 8200

Fax 609 452 6467

Web www.soligenix.com

Top Executives

Name	Age	Since	Title
W. Joost Wiersinga	-	-	Member of Melioidosis Scientific Advisory Board
James Markowitz	-	-	Member of Pediatric Crohn's Disease Medical Advisory Board
Alain H. Rook	-	-	Member of Cutaneous T-Cell Lymphoma Medical Advisory Board
Mark Schubert	-	-	Member of Oral Mucositis Medical Advisory Board
Dorothy Mary Kate Keefe	-	-	Member of Oral Mucositis Medical Advisory Board
Gary Wood	-	-	Member of Cutaneous T-Cell Lymphoma Medical Advisory Board
Jerome Bernard Zeldis	74	2011	Independent Director
Robert J. Rubin	78	2009	Independent Director
Bart Currie	-	-	Member of Melioidosis Scientific Advisory Board
Youn Kim	-	-	Member of Cutaneous T-Cell Lymphoma Medical Advisory Board
Madeleine Duvic	-	-	Member of Cutaneous T-Cell Lymphoma Medical Advisory Board
Joel Rosh	-	-	Member of Pediatric Crohn's Disease Medical Advisory Board
David AB Dance	-	-	Member of Melioidosis Scientific Advisory Board
Direk Limmathurotsakul	-	-	Member of Melioidosis Scientific Advisory Board
Jeffrey Hyams	-	-	Member of Pediatric Crohn's Disease Medical Advisory Board
Yusuf Yazici	-	2024	Member of Behcet's Disease Medical Advisory Board
Christopher J. Schaber	58	2006	Chairman of the Board of Directors, CEO & President
Andrew Sulich	-	2024	Member of Behcet's Disease Medical Advisory Board
Pietro Quaglino	-	2024	Member of European Medical Advisory Board
Gregory Anthony Lapointe	65	2009	Independent Director
Diane L. Parks	72	2019	Independent Director
Gülen Hatemi	-	2024	Member of Behcet's Disease Medical Advisory Board
Martine Bagot	-	2024	Member of European Medical Advisory Board
Johannes Nowatzky	-	2024	Member of Behcet's Disease Medical Advisory Board
Pablo Luis Ortiz-Romero	-	2024	Member of European Medical Advisory Board

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

SNGX Comments

Write your thoughts about Soligenix Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,085.83	+26.69	+0.53%
NSE All Share	138,669.38	+756.51	+0.55%
US 30	44,655.3	+22.3	+0.05%
US 500	6,380.6	+9.7	+0.15%
FTSE 100	9,108.93	-27.39	-0.30%
DAX	24,258.74	+60.46	+0.25%
South Africa Top 40	91,576.73	+55.99	+0.06%

Brent Oil	70.98	-0.70	-0.98%
Crude Oil WTI	68.53	-0.68	-0.98%
Gold	3,382.30	+1.10	+0.03%
Silver	38.073	-0.214	-0.56%
Copper	5.5965	-0.0290	-0.52%
London Cocoa	5,456.00	-134.00	-2.40%
London Wheat	175.95	-3.00	-1.68%

Nigeria 10Y	15.955	+0.000	+0.00%
Nigeria 2Y	16.474	0.000	0.00%
U.K. 10Y	4.5820	-0.0500	-1.08%
Germany 10Y	2.6850	-0.0050	-0.19%
U.S. 10Y	4.318	-0.017	-0.39%
U.S. 5Y	3.901	-0.005	-0.13%
U.S. 2Y	3.867	-0.008	-0.21%

Fidelitybk	21.400	+0.900	+4.39%
Zenith Bank	73.00	0.00	0.00%
UBA	47.85	+0.05	+0.10%
First HoldCo	35.00	-0.15	-0.43%
Guaranty Trust Holding	101.90	+3.90	+3.98%
Sterling Bank	6.960	+0.260	+3.88%
Dangote Cement	516.80	+7.20	+1.41%

Recent Quotes

Name	Price	Chg.	Chg. %
SNGX	1.2700	-0.0100	-0.78%
SIBK	30.15	+0.55	+1.86%
DCL	22,000.0	+650.0	+3.04%
6501	4,591.0	+134.0	+3.01%
IPAS	3.2500	0.0000	0.00%
Swisscanto (CH) B.	102.841	-0.275	-0.27%
UBS (Lux) Equity .	174.160	+1.290	+0.75%
LXSG	25.340	0.000	0.00%

Market Movers

Name	Last	Chg. %	Vol.
UBA	47.85	+0.10%	9.95M
Guaranty Trust Holding	101.65	+3.72%	9.80M
Cadbury Nig	69.00	-2.75%	8.58M
Nigerian Breweries	75.25	+1.69%	7.51M
Lafarge Africa	150.00	+6.91%	7.12M
Nascon	99.80	+8.48%	6.96M
Dangote Cement	517.00	+1.45%	2.14M

Name	Last	Chg. %	Vol.
Royalex	1.54	+10.00%	7.67M
Custodian Allied	36.30	+10.00%	93.21K
Union Dicon Salt	9.90	+10.00%	50.56K
Airtel Africa	2,541.50	+10.00%	0.05K
SCOA Nigeria	5.500	+10.00%	53.47K
Dangote Sugar	71.15	+9.97%	4.04M
Berger Paints	37.50	+9.97%	1.33M

Name	Last	Chg. %	Vol.
Total Nig	634.50	-10.00%	97.30K
Transcorp Power	288.00	-10.00%	16.82K
Geregu Power	1,027.40	-10.00%	865.00
Conoil	211.10	-9.98%	2.08K
FTN Cocoa Processors PLC	6.33	-9.57%	6.66M
Nahco	106.000	-9.40%	1.80M
Fidson	43.400	-1.14%	696.95K